Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Julie Isbell"'
Publikováno v:
Bone Marrow Transplantation. 53:647-650
Autor:
Leigh Greer, Darren Johnson, Julie Isbell, Haydar Frangoul, Katie Bruce, Tiffany Egan, Misty Evans, Carlos Bachier, Jennifer Domm, Minoo Battiwalla, Roy S Graham
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S218-S219
Background Plerixafor is used as an adjuvant to standard G-CSF mobilization to increases CD34+ cell mobilization and decreases the need for multiple days of collection. For patients with multiple myeloma (MM) and a collection goal of ≥5 × 10e6 CD3
Autor:
Julie Isbell, Leigh Greer, Carlos Bachier, Haydar Frangoul, Katie Bruce, Misty Evans, Darren Johnson, Jennifer Domm, Sandra Ward
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S203
Background Approximately 40-50% of HSCT are ABO incompatible and bone marrow (BM) products contain 25-35% of incompatible RBCs. RBC reduction can be performed using several different techniques including manual RBC sedimentation using hydroxyethyl st
Autor:
Jennifer Domm, Julie Isbell, Katie Bruce, Haydar Frangoul, Misty Evans, Darren Johnson, Leigh Greer, Ayad Ahmed Hussein
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S120
Introduction Allogeneic HSCT (alloHSCT) offers a potential cure for patients with AML; however, 40% of AML patients receiving alloHSCT will experience relapsed disease. Second alloHSCT can offer the best long-term survival but is associated with sign
Autor:
Julie Isbell
Publikováno v:
Journal of Christian Nursing. 26:160-161